Trial intelligence / Profile preview

Clinical Nutrition in Lung and Breast Neoplasms

NCT02603016Completed

Sponsor
Chinese PLA General Hospital
Start
Nov 2015
Primary completion
Nov 2016
Countries
1
01

Overview

Randomised, open-label trial (4 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: T-lymphocyte cell subsets at 3 months. Started Nov 2015; status: completed.

Beyond the preview

Go deeper on NCT02603016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02603016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call